Macrophage-specific Pair Immunoglobulin-like Type 2 Receptor beta (PILRB) regulation of Pulmonary Hypertension
巨噬细胞特异性免疫球蛋白样 2 型受体 β (PILRB) 对肺动脉高压的调节
基本信息
- 批准号:10281899
- 负责人:
- 金额:$ 7.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-21 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsAwardBlood VesselsCellsCellular StructuresChronicComplexDataDependenceDevelopmentDiagnosticDiseaseDisease ProgressionEndothelial CellsEnvironmentFibroblastsGene ExpressionGoalsHIF1A geneHealthHeart failureHospitalizationHumanHypoxiaHypoxia Inducible FactorIL6 geneImmuneImmunoglobulinsInflammationInflammatory ResponseInterleukin-1Interleukin-1 betaInterleukin-6Knockout MiceKnowledgeLigandsLungMediatingMediator of activation proteinMissionModelingMorbidity - disease rateMusMyeloid CellsPathogenesisPathologicPathway interactionsPatternPlayProcessProductionPulmonary FibrosisPulmonary HypertensionPulmonary Vascular ResistancePulmonary vesselsRegulationResearchRoleSecondary toSeveritiesSiteSmooth Muscle MyocytesStructure of parenchyma of lungTNF geneTestingTherapeuticTimeTissue BanksTissuesTransgenic AnimalsUnited States National Institutes of HealthUp-RegulationVascular DiseasesVascular Smooth MuscleVascular remodelingWorkcell behaviorcell typecytokinedefined contributioneffective therapyhuman diseaseimprovedinhibitor/antagonistinterstitialmacrophagemembermigrationmonocytemortalitymouse modelnew therapeutic targetnovel diagnosticsnovel therapeutic interventionpulmonary arterial hypertensionreceptorresponsetherapeutic developmenttranscriptome
项目摘要
ABSTRACT
Pulmonary hypertension (PH), arising from primary pulmonary vascular disease or secondary to many other
conditions, is associated with high morbidity and mortality. Despite recent therapeutic advancements, PH
hospitalization and mortality continue to rise. Development of effective therapy is needed but is limited by a
fundamental knowledge gap in our understanding of cells and mechanisms that regulate pulmonary vascular
remodeling underlying PH development. Macrophage (MØ) accumulation is observed in animal models and
human PH suggesting a role for monocytes/MØs in regulating PH pathogenesis, My K08 award centered on
defining the contribution of monocytes/MØs to PH pathogenesis. I demonstrated that non-classical monocytes
(NcMos) sense hypoxia, through hypoxia inducible factor-1α (HIF1α), and differentiate into pro-vascular
remodeling interstitial MØs (IMØs) that promote PH development. Effective targeting of these disease promoting
cells to alleviate disease will require an understanding of mechanisms by which they regulate vascular
remodeling. I identified paired immunoglobulin-like type 2 receptor beta (PILRβ) as a candidate NcMo-derived
IMØ-specific disease mediator. We hypothesize that, in response to hypoxia and activation of HIF1α: 1) PILRβ
expression in infiltrating IMØs is increased and 2) PILRβ engages its receptor, CD99, on vascular structural cells
(i.e. endothelial cells, vascular smooth muscle cells, and fibroblasts) to increase the production of cytokines (e.g.
TNF, IL-1β, and IL-6) that promote pulmonary vascular remodeling and PH development. Our preliminary studies
show that gene expression of PILRβ is decreased in Hif1α-deficient IMØs. This decrease is associated with
lower expression of pro-vascular remodeling cytokines (i.e. TNF, IL-1, and IL6), as well as reduced severity of
vascular remodeling and PH. These findings suggest that PILRβ is a NcMo/IMØ-specific mediator that modulates
PH pathogenesis. Utilizing transgenic animal and human PAH lung tissue collection developed during my K08
award, we propose the following specific aims: Aim 1. To determine the expression patterns of PILRβ
receptor complex and its regulation by HIF1α in a murine model and human PH. NcMo-specific Hif1α
knockout mice will be examined in a model of hypoxia-induced PH to define PILRβ expression pattern over the
course of PH development. PILRβ expression in human PAH lung will also be examined. Aim 2. To determine
the cells that express CD99, a ligand for PILRβ, and ligand expression in response to chronic hypoxia
and in human PH. CD99 expression will be examined over the course of PH development in hypoxia-induced
PH and human PAH lung explants. Aim 3. To determine cytokine response during PH development that is
modulated by infiltrating IMØs to promote vascular remodeling. Cytokine responses over the course of PH
development will be examined in NcMo-specific Hif1α knockout mice and in human PAH lung explants. The
proposed studies will provide the preliminary data to support an R01 application focused on examining PILRβ
as a potential therapeutic strategy for PH.
摘要
肺高压(PH),由原发肺血管疾病引起或继发于许多其他疾病
这种疾病与高发病率和高死亡率有关。尽管最近在治疗方面取得了进展,但PH
住院和死亡率继续上升。开发有效的治疗方法是必要的,但受到
我们对调节肺血管的细胞和机制了解的基础知识差距
重塑是PH发生的基础。巨噬细胞(M?)在动物模型和
人类PH提示单核细胞/S在调节PH发病机制中的作用,我的K08奖集中在
明确单核细胞/M?S在PH发病中的作用。我证明了非经典单核细胞
(NcMOS)通过低氧诱导因子-1α(HIF1α)感知低氧,并分化为促血管生成
重塑间质M?S(IM?S),促进PH的发展。有效针对性地促进这些疾病的发生
为了减轻疾病,细胞需要了解它们调节血管的机制
改建。我确定配对的免疫球蛋白样2型受体β(PILRβ)是NcMo来源的候选基因
IM?-特异性疾病介体。我们假设,作为对缺氧和HIF1α激活的反应:1)PILRβ
浸润性IM?S的表达增加;2)PILRβ与其受体CD99结合于血管结构细胞
(即内皮细胞、血管平滑肌细胞和成纤维细胞)以增加细胞因子的产生(例如
肿瘤坏死因子、白介素1β和白介素6)促进肺血管重塑和肺高压的发生发展。我们的初步研究
研究表明,在缺乏β的IM?S中,pILR-α的基因表达降低。
降低促血管重塑细胞因子(即肿瘤坏死因子、白介素1和白介素6)的表达,以及减轻高血压的严重程度
血管重塑与肺高压。这些发现表明,PILRβ是一种NcMo/IM?特异性的调节介质
PH发病机制。利用My K08期间开发的转基因动物和人PAH肺组织收集
目的1.确定PILRβ的表达模式
小鼠和人肺高压模型中的受体复合体及其HIF1α的调节NcMo特异性HIF1α
基因敲除小鼠将在低氧诱导的PH模型中进行检查,以确定PILRβ在
PH的发展历程。此外,还将检测PILRβ在人肺组织中的表达。目标2.确定
表达PILRβ配体CD99的细胞及其对慢性低氧反应的配体表达
在人类PH中也是如此。CD99的表达将在低氧诱导的PH形成过程中被检测
PH值和人PAH肺组织块。目的3.确定PH发育过程中的细胞因子反应,即
经调理通脉通络,促进血管重塑。PH病程中的细胞因子反应
将在NcMo特异的HIF1HIF1基因敲除小鼠和人类α肺外植体中检查发育情况。这个
拟议的研究将提供初步数据,以支持专注于检查PILRβ的R01应用程序
作为一种潜在的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yen-Rei Andrea Yu其他文献
Yen-Rei Andrea Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yen-Rei Andrea Yu', 18)}}的其他基金
Role of Resident Monocytes in the Pathogenesis of Pulmonary Arterial Hypertension
常驻单核细胞在肺动脉高压发病机制中的作用
- 批准号:
9272000 - 财政年份:2015
- 资助金额:
$ 7.78万 - 项目类别:
Role of Resident Monocytes in the Pathogenesis of Pulmonary Arterial Hypertension
常驻单核细胞在肺动脉高压发病机制中的作用
- 批准号:
8821892 - 财政年份:2015
- 资助金额:
$ 7.78万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists